ANDA 75149, held by Teva. Ticlopidine Hydrochloride.
As of Nov 16, 2026, ANDA 75149 (Ticlopidine Hydrochloride), held by Teva, was first approved by FDA on Aug 20, 1999, with 4 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 20, 1999 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Ticlopidine Hydrochloride250MG ยท tablet;oral | Ticlopidine Hydrochloride | Discontinued |
| Oct 16, 2002 | Supplement 4Labeling | Approved | None posted |
| May 28, 2002 | Supplement 3Labeling | Approved | None posted |
| Apr 20, 2001 | Supplement 2Labeling | Approved | None posted |
| Jan 29, 2001 | Supplement 1Labeling | Approved | None posted |
| Aug 20, 1999 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters